- Home
- SES vs CVRX Comparison
SES vs CVRX Comparison
Compare SES & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SES
- CVRX
- Stock Information
- Founded
- SES 2012
- CVRX 2000
- Country
- SES United States
- CVRX United States
- Employees
- SES N/A
- CVRX N/A
- Industry
- SES Auto Parts:O.E.M.
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SES Consumer Discretionary
- CVRX Health Care
- Exchange
- SES Nasdaq
- CVRX Nasdaq
- Market Cap
- SES 367.8M
- CVRX 419.8M
- IPO Year
- SES N/A
- CVRX 2021
- Fundamental
- Price
- SES $0.89
- CVRX $13.85
- Analyst Decision
- SES Sell
- CVRX Strong Buy
- Analyst Count
- SES 2
- CVRX 7
- Target Price
- SES $1.25
- CVRX $17.83
- AVG Volume (30 Days)
- SES 20.2M
- CVRX 219.8K
- Earning Date
- SES 02-25-2025
- CVRX 02-04-2025
- Dividend Yield
- SES N/A
- CVRX N/A
- EPS Growth
- SES N/A
- CVRX N/A
- EPS
- SES N/A
- CVRX N/A
- Revenue
- SES N/A
- CVRX $51,292,000.00
- Revenue This Year
- SES N/A
- CVRX $27.21
- Revenue Next Year
- SES N/A
- CVRX $25.87
- P/E Ratio
- SES N/A
- CVRX N/A
- Revenue Growth
- SES N/A
- CVRX 30.53
- 52 Week Low
- SES $0.20
- CVRX $6.40
- 52 Week High
- SES $2.53
- CVRX $22.50
- Technical
- Relative Strength Index (RSI)
- SES 41.01
- CVRX 39.53
- Support Level
- SES $0.93
- CVRX $14.07
- Resistance Level
- SES $1.35
- CVRX $15.42
- Average True Range (ATR)
- SES 0.11
- CVRX 0.88
- MACD
- SES -0.03
- CVRX -0.23
- Stochastic Oscillator
- SES 2.10
- CVRX 13.84
About SES SES AI Corporation
SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.